Cochlear (MEX:COHN) DeferredTaxAndRevenue: MXN231 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:COHN Cochlear Ltd MEX:COHN
73 GF Score
Price MXN2,391.38
GF Value MXN5,965.23
! 2 Warning Signs
View Full Analysis

What is Cochlear DeferredTaxAndRevenue?

Cochlear MEX:COHN 73 DeferredTaxAndRevenue is MXN231 Mil as of Dec. 2025. GuruFocus rates MEX:COHN with a GF Score™ of 73/100 and a GF Value™ of MXN5,965.23. The stock has 2 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Cochlear's current deferred tax and revenue for the quarter that ended in Dec. 2025 was MXN231 Mil.

Cochlear DeferredTaxAndRevenue Related Terms

Cochlear DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Cochlear's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cochlear DeferredTaxAndRevenue Chart

Cochlear Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 847.68 988.23 910.12 1,025.49 1,309.22

Cochlear Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 242.00 1,025.49 462.29 1,309.22 230.90
MEX:COHN
73GF Score
Cochlear Ltd MEX:COHN
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of MXN231 Mil mean?
Cochlear (MEX:COHN) has a DeferredTaxAndRevenue of MXN231 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Cochlear.
Is Cochlear's DeferredTaxAndRevenue too high?
Cochlear's current DeferredTaxAndRevenue is MXN231 Mil. Overall, Cochlear has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Cochlear's DeferredTaxAndRevenue compare to ABT and SYK?
Cochlear's DeferredTaxAndRevenue of MXN231 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Cochlear. Cochlear's current DeferredTaxAndRevenue is MXN231 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cochlear stock overvalued right now?
Cochlear (MEX:COHN) has a current DeferredTaxAndRevenue of MXN231 Mil. The stock's GF Value™ is MXN5,965.23, compared to a current price of MXN2,391.38 — trading 59.9% below its estimated fair value. The current DeferredTaxAndRevenue is MXN231 Mil. Cochlear's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Cochlear (MEX:COHN), the current DeferredTaxAndRevenue is MXN231 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cochlear (MEX:COHN) Overvalued in 2026?

Based on GuruFocus' analysis, Cochlear stock appears to be undervalued. The current stock price of MXN2,391.38 is trading 59.9% below its estimated GF Value™ of MXN5,965.23.

Key valuation signals for MEX:COHN:

  • DeferredTaxAndRevenue: MXN231 Mil
  • GF Value™: MXN5,965.23 vs. price of MXN2,391.38 (59.9% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the MEX:COHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cochlear Business Description

Address 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
73GF Score

Get the complete analysis for MEX:COHN

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,391.38
Price
MXN5,965.23
GF Value